EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?
EASL Studio S4E3 - A 360 approach to beat alcohol-related liver disease
EASL Studio S4E13 - JHEP Live: Liver transplantation for alcohol-related hepatitis
EASL Studio S4E22 - JHEP Live: new and promising drugs for NASH on the horizon
EASL Studio S4E10 - Ascites: New solution for an old problem
EASL Studio S4E17 - Albumin in Cirrhosis: For All, For Some, For None
S4-E12 - Deep Dive: ICER Draft Report on Resmetirom and Obeticholic Acid for NASH
EASL Studio - S2 E17 - EASL Haemochromatosis Guidelines 2022
EASL Studio S5E3 Promo Video - Zoonotic Hepatitis E – What’s hot in 2023?
EASL Studio - S3E2 - Liver transplantation for ACLF: Opportunities, challenges and pitfalls
S4E13 Promo - Liver transplantation for alcohol-related hepatitis
S4E1Promo - HBV Elimination how far are we?
Becoming Practice-Ready for Imminent NASH Drug Approvals
APASL Hepatology Webinar
💊 NASH Treatment: Review Of Current And Future Therapies For Non-Alcoholic Steatohepatitis
What are the health complications of NASH in adults? Michael Ramada, MD
Recent Advances in Non-Alcoholic Steatohepatitis "NASH"
Crucial updates on Fatty Liver disease - EASL 2023 - steatotic liver disease, MASLD, and MetALD
Resmetirom, drug being tested to fight fatty liver disease, showing promising results in Jackson...
Ojjaara for Anemia in Myelofibrosis, Resmetirom for NASH, COVID-19 Vaccine Update,...
